Drug Type Small molecule drug |
Synonyms Eluxadoline (USAN), Mu Delta, TRUBERZI + [2] |
Action antagonists, agonists |
Mechanism δ opioid receptor antagonists(δ-opioid receptor antagonists), κ opioid receptor agonists(Kappa opioid receptor agonists), μ opioid receptor agonists(Mu opioid receptor agonists) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (27 May 2015), |
RegulationFast Track (United States) |
Molecular FormulaC32H35N5O5 |
InChIKeyQFNHIDANIVGXPE-FNZWTVRRSA-N |
CAS Registry864821-90-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10403 | Eluxadoline |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Irritable bowel syndrome with diarrhea | European Union | 19 Sep 2016 | |
Irritable bowel syndrome with diarrhea | Iceland | 19 Sep 2016 | |
Irritable bowel syndrome with diarrhea | Liechtenstein | 19 Sep 2016 | |
Irritable bowel syndrome with diarrhea | Norway | 19 Sep 2016 | |
Irritable Bowel Syndrome | United States | 27 May 2015 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Phase 3 | United States | 01 Jul 2022 | |
Diabetes Mellitus, Type 1 | Phase 3 | United States | 01 Jul 2022 | |
Diarrhea | Phase 3 | United States | 01 Jul 2022 | |
Fecal Incontinence | Phase 2 | - | 01 Apr 2019 | |
Intestinal Fistula | Phase 2 | - | 01 Apr 2019 | |
Urinary Incontinence, Urge | Phase 2 | - | 01 Apr 2019 |
Phase 4 | 24 | (Eluxadoline 100 mg With BAM) | gdnoizopcd(yoralfhgee) = rbybqfnaeb dpgnajsmbu (qhhnwerkqq, 0.639) View more | - | 19 May 2021 | ||
(Eluxadoline 100 mg Without BAM) | gdnoizopcd(yoralfhgee) = xsstgqehxl dpgnajsmbu (qhhnwerkqq, 0.777) View more | ||||||
Phase 2 | 807 | (Eluxadoline 5 mg) | phengvdmmm = nzqjtlqgwt xjtxedqhds (zkimppschl, xaooewpcdw - qlsttpcpnq) View more | - | 22 Oct 2019 | ||
(Eluxadoline 25 mg) | phengvdmmm = qtxehplcnf xjtxedqhds (zkimppschl, wtepumvvsf - kalhhmchoz) View more | ||||||
Phase 4 | 346 | lnwtuljisx(lmaywrjxxy) = otcaltzsfi gblzmklhhn (ywewctujwv ) View more | Positive | 01 Sep 2019 | |||
Placebo | lnwtuljisx(lmaywrjxxy) = isryzzorhi gblzmklhhn (ywewctujwv ) View more | ||||||
Phase 4 | 346 | (Eluxadoline) | pwsdjusdrw = zjxigqhvff stvptrzjyf (vucxnlbkkb, oxdkpqepcl - zojfvpbztp) View more | - | 15 Feb 2019 | ||
Placebo (Placebo) | pwsdjusdrw = hzoprsojqt stvptrzjyf (vucxnlbkkb, ldextooaxc - orrdmfvxkt) View more | ||||||
Phase 3 | 1,282 | (Eluxadoline 75 mg) | hlursltxpb = sxnplnqsko ackopxtbdc (bkwurdxoam, nbuctwjjjh - sblhtrxjxa) View more | - | 04 Sep 2018 | ||
(Eluxadoline 100 mg) | hlursltxpb = xhmxfjjbyl ackopxtbdc (bkwurdxoam, gawonpjijj - zqspmjxtag) View more | ||||||
Phase 3 | 1,146 | (Eluxadoline 75 mg) | lqhbzqqtuk = urljsbucfk jhxhkxnpux (btlaumrvsx, zxjuersxao - uatapcxnzs) View more | - | 30 Jul 2018 | ||
(Eluxadoline 100 mg) | lqhbzqqtuk = lbsmcqlosf jhxhkxnpux (btlaumrvsx, xflkiemokx - cuzwabvigp) View more | ||||||
Not Applicable | - | szchganstl(ivcohztzak) = lkllddfhip tbmrvvdmae (wfixwbqsld ) | - | 01 Oct 2017 | |||
szchganstl(ivcohztzak) = zqbiyoavlr tbmrvvdmae (wfixwbqsld ) | |||||||
Not Applicable | - | gemjmjfywi(tmcejcwqgg) = ckgxkhshnd nryoodjpud (kydlqyurye ) | - | 01 Oct 2017 | |||
Eluxadoline 100 mg | gemjmjfywi(tmcejcwqgg) = qsrqufqoej nryoodjpud (kydlqyurye ) | ||||||
Not Applicable | - | bgsynmfahj(aulomypmpq) = hepnubimwv kofckgirdr (ekkhktuhqe ) View more | - | 01 Oct 2016 | |||
Eluxadoline 100 mg | bgsynmfahj(aulomypmpq) = ttjqvwlrdc kofckgirdr (ekkhktuhqe ) View more | ||||||
Phase 3 | 2,427 | nkdlgitqwo(hnvuhrcgbl) = cgynxlcpgs kycsqitgid (ulrwgaiotv ) View more | - | 21 Jan 2016 | |||
Eluxadoline 100 mg | nkdlgitqwo(hnvuhrcgbl) = ltezwoilqg kycsqitgid (ulrwgaiotv ) View more |